EUCTR2016-001008-49-Outside-EU/EEA进行中（未招募）1 期
A randomized, multicenter trial of oseltamivir doses of 75 mg for 5 or 10 days versus 150 mg for 5 or 10 days in influenza patients with pandemic (H1N1) 2009
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Pediatric, adolescent and adult patients >/=1 year of age
- •- Fever >/=37.8 degrees C or at least one respiratory symptom (cough, coryza, sore throat, or rhinitis)
- •- Positive rapid diagnostic test for pandemic (H1N1) 2009 virus or influenza A in the 24 hours prior to the first dose of study drug
- •- Are the trial subjects under 18? yes
- •Number of subjects for this age range: 200
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 100
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 100
排除标准
- •- Currently receiving any form of renal replacement therapy including hemodialysis, peritoneal dialysis, or hemofiltration
- •- History of chronic renal failure or clinical suspicion of renal failure at baseline
- •- Clinical evidence of hepatic compensation at the time of randomization
- •- Known HIV infection
- •- Vaccination with live attenuated influenza vaccine (LAIV) in the two weeks prior to first dose of study medication
研究者
相似试验
进行中（未招募）
不适用
An open label multi-center trial of oseltamivir for the seasonal prophylaxis of influenza in childreSeasonal prophylaxis of influenza in immunocompromised subjectsMedDRA version: 8.1Level: LLTClassification code 10022000Term: InfluenzaEUCTR2006-003284-31-DKF.Hoffmann-La Roche Ltd.50
进行中（未招募）
不适用
An open label multi-center trial of oseltamivir for the seasonal prophylaxis of influenza in childreSeasonal prophylaxis of influenza in immunocompromised subjectsMedDRA version: 8.1Level: LLTClassification code 10022000Term: InfluenzaEUCTR2006-003284-31-DEF.Hoffmann-La Roche Ltd.50
进行中（未招募）
不适用
A study to assess the safety of Oseltamivir administered in the vein for the treatment of flu (Influenza) in patients of at least 13 years of age.EUCTR2010-020083-38-DKF. Hoffmann-La Roche Ltd200
进行中（未招募）
1 期
A study to assess the safety of Oseltamivir administered in the vein for the treatment of flu (Influenza) in patients of at least 13 years of age.Treatment of Influenza [seasonal or pandemic (H1N1) 2009]MedDRA version: 14.0Level: LLTClassification code 10022001Term: Influenza (epidemic)System Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.0Level: LLTClassification code 10022003Term: Influenza B virus infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.0Level: PTClassification code 10022000Term: InfluenzaSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.0Level: LLTClassification code 10022002Term: Influenza A virus infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2010-020083-38-DEF. Hoffmann-La Roche Ltd118
进行中（未招募）
不适用
A study to assess the safety of Oseltamivir administered in the vein for the treatment of flu (Influenza) in patients of at least 13 years of age.Treatment of Influenza [seasonal or pandemic (H1N1) 2009]MedDRA version: 14.1Level: LLTClassification code 10022001Term: Influenza (epidemic)System Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.1Level: LLTClassification code 10022003Term: Influenza B virus infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.1Level: PTClassification code 10022000Term: InfluenzaSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.1Level: LLTClassification code 10022002Term: Influenza A virus infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2010-020083-38-LTF. Hoffmann-La Roche Ltd200